Peter C. Huijgens

Learn More
PURPOSE We conducted an international, randomized, phase III trial to evaluate the efficacy and safety of consolidation with yttrium-90 ((90)Y)-ibritumomab tiuxetan in patients with advanced-stage(More)
The selective uptake of the Auger- and internal conversion electrons emitting radionuclide 67Ga in malignant tumours may have therapeutic potential. We studied several factors which might affect the(More)